ABBVIE MIGRAINE CAREER CATALYST AWARD
LIVE

Add to watchlist:

No watchlists yet
View on USPTO

ABBVIE MIGRAINE CAREER CATALYST AWARD Trademark

Serial Number: 98488529

ABBVIE MIGRAINE CAREER CATALYST AWARD is a trademark filed by ALLERGAN PHARMACEUTICALS INTERNATIONAL LIMITED on April 8, 2024. The trademark is classified under Class 36 (Insurance & Financial), Class 41 (Education & Entertainment), Class 44 (Medical Services), Class 35 (Advertising & Business). The application is currently pending registration.

Owner Contact Info

ALLERGAN PHARMACEUTICALS INTERNATIONAL LIMITED (255 trademarks)

CLONSHAUGH BUSINESS & TECHNOLOGY PARK
COOLOCK, DUBLIN 17 , IE

Entity Type: 77

Trademark Details

Filing Date

April 8, 2024

Registration Date

Not Registered

Goods & Services

Arranging and conducting an award program offering career counseling for migraine sufferers.

Arranging and conducting an award program offering financial support for migraine sufferers.

Arranging and conducting an award program offering networking opportunities for migraine sufferers.

Providing a website featuring non-downloadable medical and patient assistance information directed to migraine sufferers, namely social media content, video content, presentations, audio content, and video recordings.

Filing History

PREVIOUS ALLOWANCE COUNT WITHDRAWN
Aug 7, 2025 ZZZX
WITHDRAWN FROM PUB - OG REVIEW QUERY
Jul 29, 2025 PBCR
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 26, 2025 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 25, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 25, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 25, 2025 TROA
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Mar 25, 2025 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Mar 25, 2025 XELR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Dec 26, 2024 GNRN
NON-FINAL ACTION E-MAILED
Dec 26, 2024 GNRT
NON-FINAL ACTION WRITTEN
Dec 26, 2024 CNRT
ASSIGNED TO EXAMINER
Oct 21, 2024 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 15, 2024 NWOS
NEW APPLICATION ENTERED
Apr 8, 2024 NWAP